April 2009

National Institute on Aging and HBO Produce Documentary on Alzheimer’s Disease

The National Institute on Aging (NIA) and HBO Documentary films recently partnered with the Alzheimer’s Association and several other charitable organizations to develop a series of films entitled “The Alzheimer’s Project”.  The project was created to enhance public awareness and understanding of Alzheimer’s disease and to highlight progress being made on the scientific front to combat it.  The four films that comprise the series center around the impact of the disease on those afflicted with Alzheimer’s, their caregivers, their family members, and those involved in research to find a cure.  There are also numerous supplemental films that take a more in depth look at the scientists and researchers working behind the scenes to find better treatments and potential cures for the disease.

The films will debut on the HBO network between May 10 and May 12. Following the initial screening, the films will be available for a free download online.  In addition to the film aspect of the Alzheimer’s project, a website was established to host a large amount of resources for patients and caregivers.  The online materials, created by the NIA and the Alzheimer’s Association, will help web visitors learn more about coping with an Alzheimer’s diagnosis.

To visit “The Alzheimer’s Project” website, click here.

ACT-AD Welcomes New Corporate Sponsor

Pfizer, the world’s largest research based biomedical and pharmaceutical company, recently became a legacy sponsor of the ACT-AD Coalition.  Pfizer’s support will enable the Coalition to enhance its broad range of educational and advocacy activities to elevate the priority of Alzheimer’s disease. Pfizer joins a growing list of sponsors who are committed to helping advance the mission of ACT-AD.

ACT-AD welcomes Pfizer and takes this opportunity to thank them and our other sponsors for allowing the Coalition to more effectively highlight increasing scientific knowledge from the field AD research and the impact that could have on those affected by Alzheimer’s disease and their families and caregivers.